References

1. Liu, Z.; Zhou, T.; Ziegler, A.C.; Dimitrion, P.; Zuo, L. oxidative stress in neurodegenerative diseases: From molecular mechanisms to clinical applications. Oxid. Med. Cell. Longev. 2017, 2017, 2525967.
2. Ramos-Hryb, A.B.; Pazini, F.L.; Kaster, M.P.; Rodrigues, A.L.S. Therapeutic potential of ursolic acid to manage neurodegenerative and psychiatric diseases. CNS Drugs 2017, 31, 1029–1041.
3. Salau, V.F.; Erukainure, O.L.; Ayeni, G.; Ibeji, C.U.; Islam, S. Modulatory effect of ursolic acid on neurodegenerative activities in oxidative brain injury: An ex vivo study. J. Food Biochem. 2021, 45, e13597.
4. Bacci, A.; Runfola, M.; Sestito, S.; Rapposelli, S. Beyond antioxidant effects: Nature-based templates unveil new strategies for neurodegenerative diseases. Antioxidants 2021, 10, 367.
5. Alqahtani, A.; Hamid, K.; Kam, A.; Wong, K.H.; Abdelhak, Z.; Razmovski-Naumovski, V.; Chan, K.; Li, K.M.; Groundwater, P.W.; Li, G.Q. The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Curr. Med. Chem. 2013, 20, 908–931.
6. Kashyap, D.; Tuli, H.S.; Sharma, A.K. Ursolic acid (UA): A metabolite with promising therapeutic potential. Life Sci. 2016, 146, 201–213.
7. Proshkin, E.; Plyusnin, S.; Babak, T.; Lashmanova, E.; Maganova, F.; Koval, L.; Platonova, E.; Shaposhnikov, M.; Moskalev, A. Terpenoids as potential geroprotectors. Antioxidants 2020, 9, 529.
8. Shanmugam, M.K.; Nguyen, A.H.; Kumar, A.P.; Tan, B.K.H.; Sethi, G. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer. Cancer Lett. 2012, 320, 158–170.
9. Laszczyk, M.N. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med. 2009, 75, 1549–1560.
10. Jäger, S.; Trojan, H.; Kopp, T.; Laszczyk, M.N.; Scheffler, A. Pentacyclic triterpene distribution in various plants—Rich sources for a new group of multi-potent plant extracts. Molecules 2009, 14, 2016–2031.
11. Hill, R.A.; Connolly, J.D. Triterpenoids. Nat. Prod. Rep. 2013, 30, 1028–1065.
12. Guinda, A.; Rada, M.; Delgado, T.; Gutiérrez-Adánez, P.; Castellano, J.M. Pentacyclic triterpenoids from olive fruit and leaf. J. Agric. Food Chem. 2010, 58, 9685–9691.
13. Yoo, K.Y.; Park, S.Y. Terpenoids as potential anti-Alzheimer’s disease therapeutics. Molecules 2012, 17, 3524–3538.
14. Shanmugam, M.K.; Dai, X.; Kumar, A.P.; Tan, B.K.H.; Sethi, G.; Bishayee, A. Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies. Biochem. Pharmacol. 2013, 85, 1579–1587.
15. Woźniak, Ł.; Skąpska, S.; Marszałek, K. Ursolic acid—A pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules 2015, 20, 20614–20641.
16. Castellano, J.M.; Garcia-Rodriguez, S.; Espinosa, J.M.; Millan-Linares, M.C.; Rada, M.; Perona, J.S. Oleanolic acid exerts a neuroprotective efect against microglial cell activation by modulating cytokine release and antioxidant defense systems. Biomolecules 2019, 9, 683.
17. Pollie, J.; Goossens, A. Oleanolic acid. Phytochemistry 2012, 77, 10–15.
18. Jesus, J.A.; Lago, J.H.G.; Laurenti, M.D.; Yamamoto, E.S.; Passero, L.F.D. antimicrobial activity of oleanolic and ursolic acids: An Update. Extracts rich in both ursolic and oleanolic acids. J. Evid. Based Complementary Altern. Med. 2015, 2015, 620472.
19. Cargnin, S.T.; Gnoatto, S.B. Ursolic acid from apple pomace and traditional plants: A valuable triterpenoid with functional properties. Food Chem. 2017, 220, 477–489.
20. Pironi, A.M.; de Araújo, P.R.; Fernandes, M.A.; Salgado, H.R.N.; Chorilli, M. Characteristics, biological properties and analytical methods of ursolic acid: A Rrview. Crit Rev. Anal. Chem. 2018, 48, 86–93.
21. Lim, S.W.; Hong, S.P.; Jeong, S.W.; Kim, B.; Bak, H.; Ryoo, H.C.; Lee, S.H.; Ahn, S.K. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-α. J. Dermatol. 2007, 34, 625–634.
22. Lopez-Hortas, L.; Perez-Larran, P.; Gonzalez-Munoz, M.J.; Falque, E.; Dominguez, H. Recent developments on the extraction and application of ursolic acid. A review. Food Res. Int. 2018, 103, 130–149.
23. FooDB. FoodDB Website. Available online: (accessed on 20 April 2021).
24. Sporn, M.B.; Liby, K.T.; Yore, M.M.; Fu, L.; Lopchuk, J.M.; Gribble, G.W. New synthetic triterpenoids: Potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J. Nat. Prod. 2011, 74, 537–545.
25. Kowalski, R. Studies of selected plant raw materials as alternative sources of triterpenes of oleanolic and ursolic acid types. J. Agric. Food Chem. 2007, 55, 656–662.
26. Ludeña-Huaman, M.A.; Ramos-Inquiltupa, D.A. Determination of the content of ursolic and oleanolic acid in the cuticular wax of fruits of different species of Rosaceae. Rev. Colomb. Quim. 2019, 48, 15–20.
27. Szakiel, A.; Pączkowski, C.; Pensec, F.; Bertsch, C. Fruit cuticular waxes as a source of biologically active triterpenoids. Phytochem. Rev. 2012, 11, 263–284.
28. Santos, H.M., Jr.; Lopes, K.C.; Alves, D.S.; Carvalho, G.A.; Oliveira, D.F. Ursolic acid and cis-tiliroside produced by Merremia tomentosa affect oviposition of Leucoptera coffeella on coffee plants. Quim Nova 2018, 41, 302–309.
29. Hashmi, M.A.; Khan, A.; Hanif, M.; Farooq, U.; Perveen, S. Traditional uses, phytochemistry, and pharmacology of olea europaea (olive). Evid. Based Complementary Altern. Med. 2015, 541591.
30. Fischer, N.H.; Williamson, G.B.; Weidenhamer, J.D.; Richardson, D.R. In search of allelopathy in Florida scrub: The role of allelopathy. J. Chem. Ecol. 1994, 20, 1355–1380.
31. Wang, C.M.; Chen, H.T.; Li, T.C.; Weng, J.H.; Jhan, Y.L.; Lin, S.X.; Chou, C.H. The role of pentacyclic triterpenoids in the allelopathic effects of Alstonia scholaris. J. Chem. Ecol. 2014, 40, 90–98.
32. Zhou, C.; Chen, K.; Sun, C.; Chen, Q.; Zhang, W.; Li, X. Determination of oleanolic acid, ursolic acid and amygdalin in the flower of Eriobotrya japonica lindl. by HPLC. Biomed. Chromatogr. 2007, 21, 755–761.
33. Xia, E.Q.; Yu, Y.Y.; Xu, X.R.; Deng, G.F.; Guo, Y.J.; Li, H.B. Ultrasound-assisted extraction of oleanolic acid and ursolic acid from ligustrum lucidum ait. Ultrason. Sonochem. 2011, 19, 772–776.
34. Zhou, C.; Zhang, Y.; Sheng, Y.; Zhao, D.; Lv, S.; Hu, Y.; Tao, J. Herbaceous peony (Paeonia lactiflora Pall.) as an alternative source of oleanolic and ursolic acids. Int. J. Mol. Sci. 2011, 12, 655–667.
35. Misra, R.C.; Maiti, P.; Chanotiya, C.S.; Shanker, K.; Ghosh, S. Methyl jasmonate-elicited transcriptional responses and pentacyclic triterpene biosynthesis in sweet basil. Plant. Physiol. 2021, 164, 1028–1044.
36. Sut, S.; Zengin, G.; Maggi, F.; Malagoli, M.; Dall’Acqua, S. Triterpene acid and phenolics from ancient apples of Friuli Venezia Giulia as nutraceutical ingredients: LC-MS study and in vitro activities. Molecules 2019, 24, 1109.
37. Butkevičiūtė, A.; Liaudanskas, M.; Kviklys, D.; Zymonė, K.; Raudonis, R.; Viškelis, J.; Uselis, N.; Janulis, V. Detection and analysis of triterpenic compounds in apple extracts. Int. J. Food Prop. 2018, 21, 1716–1727.
38. Butkevičiūtė, A.; Liaudanskas, M.; Kviklys, D.; Gelvonauskienė, D.; Janulis, V. Qualitative and quantitative composition of triterpenic compounds in the fruit of apple old cultivars grown in Lithuania. Agriculture 2021, 108, 63–70.
39. Viškelis, J.; Uselis, N.; Liaudanskas, M.; Lanauskas, J.; Bielicki, P.; Univer, T.; Lepsis, J.; Kviklys, D. Location effects across northeastern Europe on bioactive compounds in apple fruit. Agric. Food Sci. 2019, 28, 93–100.
40. Zhou, C.; Sheng, Y.; Zhao, D.; Wang, Z.; Tao, J. Variation of oleanolic and ursolic acid in the flesh of persimmon fruit among different cultivars. Molecules 2010, 15, 6580–6587.
41. Zhang, F.; Daimaru, E.; Ohnishi, M.; Kinoshita, M.; Tokuji, Y. Oleanolic acid and ursolic acid in commercial dried fruits. Food Sci. Technol. Res. 2013, 19, 113–116.
42. Xia, E.Q.; Wang, B.W.; Xu, X.R.; Zhu, L.; Song, Y.; Li, H.B. Microwave-assisted extraction of oleanolic acid and ursolic acid from ligustrum lucidum. ait. Int. J. Mol. Sci. 2011, 12, 5319–5329.
43. Fu, Q.; Zhang, L.; Cheng, N.; Jis, M.; Zhang, Y. Extraction optimization of oleanolic and ursolic acids from pomegranate (Punica granatum L.) flowers. Food Bioprod. Process. 2014, 92, 321–327.
44. Cláudio, A.F.M.; Cognigni, A.; De Faria, E.L.P.; Silvestr, A.J.D.; Zirbs, R.; Freire, M.G.; Bica, K. Valorization of olive tree leaves: Extraction of oleanolic acid using aqueous solutions of surface-active ionic liquids. Sep. Purif. Technol. 2018, 204, 30–37.
45. Kosior, M.J.; Sowa, I.; Kocjan, R.; Nowak, R. Effect of different extraction techniques on quantification of oleanolic and ursolic acid in Lamii albi flos. Ind. Crops Prod. 2013, 44, 373–377.
46. Fan, J.P.; Liao, D.D.; Zhang, X.H. Ultrasonic assisted extraction of ursolic acid from apple pomace: A novel and facile technique. Sep. Sci. Technol. 2016, 51, 1344–1350.
47. Furtado, N.A.J.C.; Pirson, L.; Edelberg, H.; Miranda, L.M.; Loira-Pastoriza, C.; Preat, V.; Larondelle, Y.; André, C.M. Pentacyclic triterpene bioavailability: An overview of in vitro and in vivo studies. Molecules 2017, 22, 400.
48. Tong, H.H.Y.; Du, Z.; Wang, G.N.; Chan, H.M.; Chang, Q.; Lai, L.C.M.; Chow, A.H.L.; Zheng, Y. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound. Int. J. Pharm. 2011, 404, 148–158.
49. Gao, S.; Basu, S.; Yang, Z.; Deb, A.; Hu, M. bioavailability challenges associated with development of saponins as therapeutic and chemopreventive agents. Curr. Drug Targets 2012, 13, 1885–1899.
50. Kalani, K.; Yadav, D.K.; Khan, F.; Srivastava, S.K.; Suri, N. Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity. J. Mol. Model. 2012, 18, 3389–3413.
51. Kashyap, D.; Tuli, H.S.; Yerer, M.B.; Sharma, A.; Sak, K.; Srivastava, S.; Pandey, A.; Garg, V.K.; Sethi, G.; Bishayee, A. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Semin. Cancer Biol. 2021, 69, 5–23.
52. Song, J.; Wang, Y.; Song, Y.; Chan, H.; Bi, C.; Yang, X.; Yan, R.; Wang, Y.; Zheng, Y. Development and characterisation of ursolic acid nanocrystals without stabiliser having improved dissolution rate and in vitro anticancer activity. AAPS PharmSciTech 2014, 15, 11–19.
53. Jiang, Q.; Yang, X.; Du, P.; Zhang, H.; Zhang, T. Dual strategies to improve oral bioavailability of oleanolic acid: Enhancing water-solubility, permeability and inhibiting cytochrome P450 isozymes. Eur. J. Pharm. Biopharm. 2016, 99, 65–72.
54. Yang, L.; Sun, Z.; Zu, Y.; Zhao, C.; Sun, X.; Zhang, Z.; Zhang, L. Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process. Food Chem. 2012, 132, 319–325.
55. Eloy, J.O.; Marchetti, J.M. Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: A comparative study of fusion and solvent methods. Powder Technol. 2014, 253, 98–106.
56. Ren, Y.; Liu, Y.; Yang, Z.; Niu, R.; Gao, K.; Yang, B.; Liao, X.; Zhang, J. Solid inclusion complexes of oleanolic acid with amino-appended β-cyclodextrins (ACDs): Preparation, characterization, water solubility and anticancer activity. Mater. Sci. Eng. C 2016, 69, 68–76.
57. Qiang, Z.; Ye, Z.; Hauck, C.; Murphy, P.A.; Mc Coy, J.A.; Widrlechne, M.P.; Reddy, M.B.; Hendrich, S. Permeability of rosmarinic acid in Prunella vulgaris and ursolic acid in Salvia officinalis extracts across Caco-2 cell monolayers. J. Ethnopharmacol. 2011, 137, 1107–1112.
58. Jinhua, W.; Ying, Z.; Yuhua, L. PXR–ABC drug transporters/CYP-mediated ursolic acid transport and metabolism in vitro and vivo. Arch. Pharm. 2020, 353, e2000082.
59. Zhou, X.J.; Hu, X.M.; Yi, Y.M.; Wan, J. Preparation and body distribution of freeze-dried powder of ursolic acid phospholipid nanoparticles. Drug Dev. Ind. Pharm. 2009, 35, 305–310.
60. Chen, Q.; Luo, S.; Zhang, Y.; Chen, Z. Development of a liquid chromatography—Mass spectrometry method for the determination of ursolic acid in rat plasma and tissue: Application to the pharmacokinetic and tissue distribution study. Anal. Bioanal. Chem. 2011, 399, 2877–2884.
61. Shanmugam, M.K.; Ong, T.H.; Kumar, A.P.; Lun, C.K.; Ho, P.C.; Wong, P.T.H.; Hui, K.M.; Sethi, G. Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS ONE 2012, 7, 1–9.
62. Ge, Z.Q.; Du, X.Y.; Huang, X.N.; Qiao, B. Enhanced oral bioavailability of ursolic acid nanoparticles via antisolvent precipitation with TPGS1000 as a stabilizer. J. Drug Deliv. Sci. Technol. 2015, 29, 210–217.
63. Jeong, D.W.; Kim, Y.H.; Kim, H.H.; Ji, H.Y.; Yoo, S.D.; Choi, W.R.; Lee, S.M.; Han, C.K.; Lee, H.S. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm. Drug. Dispos. 2007, 28, 135–143.
64. Xi, J.; Chang, Q.; Chan, C.K.; Meng, Z.Y.; Wang, G.N.; Sun, J.B. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech 2009, 10, 172–182.
65. Cao, F.; Gao, Y.; Wang, M.; Fang, L.; Ping, Q. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: Synthesis, intestinal permeability, and pharmacokinetics. Mol. Pharm. 2013, 10, 1378–1387.
66. Li, Y.; Liu, H.; Guo, B.; Li, Y.; Geng, Y.; Zhao, F.; Zhang, T. Enhancement of dissolution rate and oral bioavailability in beagle dogs of oleanolic acid by adsorbing onto porous silica using supercritical carbon dioxide. J. Drug Deliv. Sci. Technol. 2014, 24, 380–385.
67. Song, M.; Hang, T.J.; Wang, Y.; Jiang, L.; Wu, X.L.; Zhang, Z.; Shen, J.; Zhang, Y. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J. Pharm. Biomed. Anal. 2006, 40, 190–196.
68. Rada, M.; Castellano, J.M.; Perona, J.S.; Guinda, Á. GC-FID determination and pharmacokinetic studies of oleanolic acid in human serum. Biomed. Chromatogr. 2015, 29, 1687–1692.
69. De la Torre, R.; Carbó, M.; Pujadas, M.; Biel, S.; Mesa, M.D.; Covas, M.I.; Exposito, M.; Espejo, J.A.; Sanchez-Rodrigues, E.; Diaz-Pellicer, P.; et al. Pharmacokinetics of maslinic and oleanolic acids from olive oil—Effects on endothelial function in healthy adults. A randomized, controlled, dose–response study. Food Chem. 2020, 322, 126676.
70. Yin, M.C.; Lin, M.C.; Mong, M.C.; Lin, C.Y. Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice. J. Agric. Food Chem. 2012, 60, 7697–7701.
71. Tsai, S.J.; Yin, M.C. Anti-oxidative, anti-glycative and anti-apoptotic effects of oleanolic acid in brain of mice treated by d-galactose. Eur. J. Pharmacol. 2012, 689, 81–88.
72. Lu, Y.F.; Wan, X.L.; Xu, Y.; Liu, J. Repeated oral administration of oleanolic acid produces cholestatic liver injury in mice. Molecules 2013, 18, 3060–3071.
73. Wang, X.H.; Zhou, S.Y.; Qian, Z.Z.; Zhang, H.L.; Qiu, L.H.; Song, Z.; Zhao, J.; Wang, P.; Hao, X.S.; Wang, H.Q. Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors. Expert Opin. Drug Metab. Toxicol. 2013, 9, 117–125.
74. Khan, K.; Aqil, M.; Imam, S.S.; Ahad, A.; Moolakkadath, T.; Sultana, Y.; Mujeeb, M. Ursolic acid loaded intra nasal nano lipid vesicles for brain tumour: Formulation, optimization, in-vivo brain/plasma distribution study and histopathological assessment. Biomed. Pharmacother. 2018, 106, 1578–1585.
75. Hu, X.; Shen, Y.; Yang, S.; Lei, W.; Luo, C.; Hou, Y.; Bai, G. Metabolite identification of ursolic acid in mouse plasma and urine after oral administration by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. RSC Adv. 2018, 8, 6532–6539.
76. Pozo, O.J.; Pujadas, M.; Gleeson, S.B.; Mesa-García, M.D.; Pastor, A.; Kotronoulas, A.; Fito, M.; Covas, M.I.; Navarro, J.R.F.; Espejo, J.A.; et al. Liquid chromatography tandem mass spectrometric determination of triterpenes in human fluids: Evaluation of markers of dietary intake of olive oil and metabolic disposition of oleanolic acid and maslinic acid in humans. Anal. Chim. Acta 2017, 990, 84–95.
77. Chen, Y.; Qi, C.; Huang, J.; Tang, X.; Li, C.; Huang, K.; Xu, J.; Guo, G. The role of astrocytes in oxidative stress of central nervous system: A mixed blessing. Cell Prolif. 2020, 53, e12781.
78. Srinivasan, R.; Aruna, A.; Lee, J.S.; Kim, M.; Shivakumar, M.S.; Natarajan, D. Antioxidant and antiproliferative potential of bioactive molecules ursolic acid and thujone isolated from memecylon edule and elaeagnus indica and their inhibitory effect on topoisomerase II by molecular docking approach. BioMed Res. Int. 2020, 2020, 8716927.
79. Shihab, Y.H.; Cheinc, Y.C.; Wangd, J.Y.; Fue, Y.S. Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats. Neurosci. Lett. 2004, 362, 136–140.
80. Zhang, T.; Su, J.; Wang, K.; Zhu, T.; Li, X. Ursolic acid reduces oxidative stress to alleviate early brain injury following experimental subarachnoid hemorrhage. Neurosci. Lett. 2014, 579, 12–17.
81. Peshattiwara, V.; Mukea, S.; Kaikinia, A.; Baglea, S.; Dighe, V.; Sathaye, S. Mechanistic evaluation of ursolic acid against rotenone induced Parkinson’s disease—Emphasizing the role of mitochondrial biogenesis. Brain Res. Bull. 2020, 160, 150–161.
82. Rai, S.N.; Zahra, W.; Singh, S.S.; Birla, H.; Keswani, C.; Dilnashin, H.; Rathore, A.S.; Singh, R.; Singh, R.K.; Singh, S.P. Anti-inflammatory activity of ursolic acid in MPTP-induced parkinsonian mouse model. Neurotox. Res. 2019, 36, 452–462.
83. Ding, H.; Wang, H.; Zhu, L.; Wei, W. Ursolic acid ameliorates early brain injury after experimental traumatic brain injury in mice by activating the Nrf2 pathway. Neurochem. Res. 2017, 42, 337–346.
84. Lia, L.; Zhanga, X.; Cuia, L.; Wanga, L.; Liua, H.; Jia, H.; Dua, Y. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice. Brain Res. Bull. 2013, 1497, 32–39.
85. Msibi, Z.N.P.; Mabandla, M.V. Oleanolic acid mitigates 6-hydroxydopamine neurotoxicity by attenuating intracellular ROS in PC12 cells and striatal microglial activation in rat brains. Front. Physiol. 2019, 10, 1059.
86. Rong, Z.T.; Gong, X.J.; Sun, H.B.; Li, J.M.; Ji, H. Protective effects of oleanolic acid on cerebral ischemic damage in vivo and H2O2-induced injury in vitro. Pharm. Biol. 2011, 49, 78–85.
87. Fricker, M.; Tolkovsky, A.M.; Borutaite, V.; Coleman, M.; Brown, G.C. Neuronal cell death. Physiol. Rev. 2018, 98, 813–880.
88. DiSabato, D.J.; Quan, N.; Godbout, J.P. Neuroinflammation: The devil is in the details. J. Neurochem. 2016, 139, 136–153.
89. Aggarwal, B.B.; Gupta, S.C.; Kim, J.H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 2012, 119, 651–665.
90. Lu, J.; Wu, D.M.; Zheng, Y.L.; Hu, B.; Zhang, Z.F.; Ye, Q.; Liu, C.M.; Shan, Q.; Wang, Y.J. Ursolic acid attenuates D-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-κB pathway activation. Cereb. Cortex 2010, 20, 2540–2548.
91. Wang, Y.; He, Z.; Deng, S. Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury. Drug Des. Devel. Ther. 2016, 10, 1663–1674.
92. Honarvara, F.; Hojatia, V.; Bakhtiarib, N.; Vaezia, G.; Myelin, M.J. Protection by ursolic acid in cuprizone-induced demyelination in mice. Iran. J. Pharm. Res. 2019, 18, 1978–1988.
93. Zhanga, Y.; Lia, X.; Cirica, B.; Curtisc, M.T.; Chend, W.J.; Rostamia, A.; Zhanga, G.X. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proc. Natl. Acad. Sci. USA 2020, 117, 9082–9093.
94. Ricote, M.; Li, A.C.; Willson, T.M.; Kelly, C.J.; Glass, C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391, 79–82.
95. Heneka, M.T.; Klockgether, T.; Feinstein, D.L. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J. Neurosci. 2000, 20, 6862–6867.
96. Kapadia, R.; Yi, J.H.; Vemuganti, R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front. Biosci. 2008, 13, 1813–1826.
97. Lenglet, S.; Montecucco, F.; Mach, F. Role of matrix metalloproteinases in animal models of ischemic stroke. Curr. Vasc. Pharmacol. 2015, 13, 161–166.
98. Villapol, S. Roles of peroxisome proliferator-activated receptor-gamma on brain and peripheral inflammation. Cell. Mol. Neurobiol. 2018, 38, 121–132.
99. Li, J.; Wang, R.; Zhang, Y.; Jia, R.; Zhao, K.; Zhang, S.; Liang, H. Protective effect of ursolic acid on ischemic brain injury by regulating hypoxia-inducible factor 1-alpha. Int. J. Clin. Exp. Med. 2019, 12, 3612–3621.
100. Arandarcikaite, O.; (Lithuanian University of Health Sciences, Kaunas, Lithuania); Liobikas, J.; (Lithuanian University of Health Sciences, Kaunas, Lithuania). Personal Communication, 2021.
101. Liobikas, J.; Majiene, D.; Trumbeckaite, S.; Kursvietiene, L.; Masteikova, R.; Kopustinskiene, D.M.; Savickas, A.; Bernatoniene, J. Uncoupling and antioxidant effects of ursolic acid in isolated rat heart mitochondria. J. Nat. Prod. 2011, 74, 1640–1644.
102. Caltana, L.; Rutolo, D.; Nieto, M.L.; Brusco, A. Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats. Neurochem. Int. 2014, 79, 79–87.
103. Strickland, M.; Stoll, E.A. Metabolic reprogramming in glioma. Front. Cell Dev. Biol. 2017, 5, 43.
104. Gu, J.; Wang, J.; Liu, X.; Sai, K.; Mai, J.; Xing, F.; Chen, Z.; Yang, X.; Lu, W.; Guo, C.; et al. IL-6 derived from therapy-induced senescence facilitates the glycolytic phenotype in glioblastoma cells. Am. J. Cancer Res. 2021, 11, 458–478.
105. Stupp, R.; Hegi, M.E.; Mason, W.P.; van den Bent, M.J.; Taphoorn, M.J.B.; Janzer, R.C.J.; Ludwin, S.K.; Allgeier, A.; Fisher, B.; Belanger, K.; et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009, 10, 459–466.
106. Umans, R.A.; Sontheimer, H. Combating malignant astrocytes: Strategies mitigating tumor invasion. Neurosci. Res. 2018, 126, 22–30.
107. Safari, M.; Khoshnevisan, A. Cancer stem cells and chemoresistance in glioblastoma multiform: A review article. J. Stem Cells 2015, 10, 271–285.
108. Seystahl, K.; Wick, W.; Weller, M. Therapeutic options in recurrent glioblastoma—An update. Crit. Rev. Oncol. Hematol. 2016, 99, 389–408.
109. Mlala, S.; Oyedeji, A.O.; Gondwe, M.; Oyedeji, O.O. Ursolic acid and its derivatives as bioactive agents. Molecules 2019, 24, 2751.
110. Hodon, J.; Borkova, L.; Pokorny, J.; Kazakova, A.; Urban, M. Design and synthesis of pentacyclic triterpene conjugates and their use in medicinal research. Eur. J. Med. Chem. 2019, 182, 111653.
111. Silva, A.M.; Alvarado, H.L.; Abrego, G.; Martins-Gomes, C.; Garduño-Ramirez, M.L.; García, M.L.; Calpena, A.C.; Souto, E.B. In vitro cytotoxicity of oleanolic/ursolic acids-loaded in plga nanoparticles in different cell lines. Pharmaceuticals 2019, 11, 362.
112. Borková, L.; Frydrych, I.; Jakubcová, N.; Adáme, R.; Lišková, B.; Gurská, S.; Medvedíková, M.; Hajdúch, M.; Urban, M. Synthesis and biological evaluation of triterpenoid thiazoles derived from betulonic acid, dihydrobetulonic acid, and ursonic acid. Eur. J. Med. Chem. 2020, 185, 111806.
113. Khwaza, V.; Oyedeji, O.O.; Aderibigbe, B.A. Ursolic acid-based derivatives as potential anti-cancer agents: An update. Int. J. Mol. Sci. 2020, 21, 5920.
114. Weng, H.; Tan, Z.; Hu, Y.; Shu, Y.; Bao, R.; Jiang, L.; Wu, X. Ursolic acid induces cell cycle arrest and apoptosis of gallbladder carcinoma cells. Cancer Cell Int. 2014, 14, 1–10.
115. Byun, H.S.; Zhou, W.; Park, I.; Kang, K.; Lee, S.R.; Piao, X.; Park, J.B.; Kwon, T.K.; Na, M.; Hur, G.M. C-27-carboxylated oleanane triterpenoids up-regulate TRAIL DISC assembly via p38 MAPK and CHOP-mediated DR5 expression in human glioblastoma cells. Biochem. Pharmacol. 2018, 158, 243–260.
116. Gao, X.; Deeb, D.; Jian, H.; Liu, Y.; Dulchavsky, S.A.; Gautam, S.C. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling. J. Neurooncol. 2007, 84, 147–157.
117. Kim, G.J.; Jo, H.J.; Lee, K.J.; Choi, J.W.; An, J.H. Oleanolic acid induces p53-dependent apoptosis via the ERK/JNK/AKT pathway in cancer cell lines in prostatic cancer xenografts in mice. Oncotarget 2018, 9, 26370–26386.
118. Conway, G.E.; Zizyte, D.; Mondala, J.R.M.; He, Z.; Lynam, L.; Lecourt, M.; Barcia, C.; Howe, O.; Curtin, J.F. Ursolic acid inhibits collective cell migration and promotes JNK-dependent lysosomal associated cell death in glioblastoma multiforme cells. Pharmaceuticals 2021, 14, 91.
119. Wang, J.; Li, Y.; Wang, X.; Jiang, C. Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-β1/miR-21/PDCD4 pathway. Basic Clin. Pharmacol. Toxicol. 2012, 111, 106–112.
120. Lu, C.C.; Huang, B.R.; Liao, P.J.; Yen, G.C. Ursolic acid triggers nonprogrammed death (necrosis) in human glioblastoma multiforme DBTRG-05MG cells through MPT pore opening and ATP decline. Mol. Nutr. Food Res. 2014, 58, 2146–2156.
121. Shen, S.; Zhang, Y.; Zhang, R.; Tu, X.; Gong, X. Ursolic acid induces autophagy in U87MG cells via ROS-dependent endoplasmic reticulum stress. Chem. Biol. Interact. 2014, 218, 28–41.
122. Frolova, T.S.; Lipeeva, A.V.; Baev, D.S.; Tsepilov, Y.A.; Sinitsyna, O.I. Apoptosis as the basic mechanism of cytotoxic action of ursolic and pomolic acids in glioma cells. Mol. Biol. 2017, 51, 809–816.
123. Zhu, Z.; Du, S.; Ding, F.; Guo, S.; Ying, G.; Yan, Z. Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression. Am. J. Transl. Res. 2016, 8, 3299–3308.
124. Huang, H.C.; Huang, C.Y.; Lin-Shiau, S.Y.; Lin, J.K. Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression. Mol. Carcinog. 2009, 48, 517–531.
125. Mazumder, K.; Siwu, E.R.O.; Nozaki, S.; Watanabe, Y.; Tanaka, K.; Fukase, K. Ursolic acid derivatives from Bangladeshi medicinal plant, Saurauja roxburghii: Isolation and cytotoxic activity against A431 and C6 glioma cell lines. Phytochem. Lett. 2011, 4, 287–291.
126. Bergamin, L.S.; Figueiró, F.; Dietrich, F.; Manica, F.M.; Filippi-Chiela, E.C.; Mendes, F.B.; Jandrey, E.H.F.; Lopes, D.V.; Oliveira, F.H.; Nascimento, I.C.; et al. Interference of ursolic acid treatment with glioma growth: An in vitro and in vivo study. Eur. J. Pharmacol. 2017, 811, 268–275.
127. Wang, H.; Zhang, Y.; Yu, W.; Xue, Y.; Xiao, L.; Xu, H. Hypoxia imaging and biological evaluation of the radiosensitizing effect of oleanolic acid. Biomed. Res. Int. 2018, 2018, 2694679.
128. Gudoityte, E. Effects of Ursolic Acid on Astroglial Cell Cultures. Master’s Thesis, Lithuanian University of Health Sciences, Kaunas, Lithuania, 2020.